Cargando…
Targeting ferroptosis in breast cancer
Ferroptosis is a recently discovered distinct type of regulated cell death caused by the accumulation of lipid-based ROS. Metabolism and expression of specific genes affect the occurrence of ferroptosis, making it a promising therapeutic target to manage cancer. Here, we describe the current status...
Autores principales: | Li, Zhaoqing, Chen, Lini, Chen, Cong, Zhou, Yulu, Hu, Dengdi, Yang, Jingjing, Chen, Yongxia, Zhuo, Wenying, Mao, Misha, Zhang, Xun, Xu, Ling, Wang, Linbo, Zhou, Jichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643412/ https://www.ncbi.nlm.nih.gov/pubmed/33292585 http://dx.doi.org/10.1186/s40364-020-00230-3 |
Ejemplares similares
-
Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis
por: Chen, Cong, et al.
Publicado: (2022) -
Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient
por: Li, Zhaoqing, et al.
Publicado: (2021) -
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
por: Yang, Jingjing, et al.
Publicado: (2021) -
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2021) -
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2022)